GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » PURE Bioscience Inc (OTCPK:PURE) » Definitions » EV-to-FCF

PURE (PURE Bioscience) EV-to-FCF : -3.77 (As of Dec. 12, 2024)


View and export this data going back to 1996. Start your Free Trial

What is PURE Bioscience EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, PURE Bioscience's Enterprise Value is $9.54 Mil. PURE Bioscience's Free Cash Flow for the trailing twelve months (TTM) ended in Jul. 2024 was $-2.53 Mil. Therefore, PURE Bioscience's EV-to-FCF for today is -3.77.

The historical rank and industry rank for PURE Bioscience's EV-to-FCF or its related term are showing as below:

PURE' s EV-to-FCF Range Over the Past 10 Years
Min: -89.25   Med: -7.53   Max: 249.69
Current: -4.08

During the past 13 years, the highest EV-to-FCF of PURE Bioscience was 249.69. The lowest was -89.25. And the median was -7.53.

PURE's EV-to-FCF is ranked worse than
100% of 1194 companies
in the Consumer Packaged Goods industry
Industry Median: 17.32 vs PURE: -4.08

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2024-12-12), PURE Bioscience's stock price is $0.06758. PURE Bioscience's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jul. 2024 was $-0.030. Therefore, PURE Bioscience's PE Ratio (TTM) for today is At Loss.


PURE Bioscience EV-to-FCF Historical Data

The historical data trend for PURE Bioscience's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PURE Bioscience EV-to-FCF Chart

PURE Bioscience Annual Data
Trend Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 197.50 -20.43 -7.54 -2.85 -4.55

PURE Bioscience Quarterly Data
Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.85 -3.36 -5.03 -3.75 -4.55

Competitive Comparison of PURE Bioscience's EV-to-FCF

For the Household & Personal Products subindustry, PURE Bioscience's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PURE Bioscience's EV-to-FCF Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, PURE Bioscience's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where PURE Bioscience's EV-to-FCF falls into.



PURE Bioscience EV-to-FCF Calculation

PURE Bioscience's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=9.535/-2.531
=-3.77

PURE Bioscience's current Enterprise Value is $9.54 Mil.
PURE Bioscience's Free Cash Flow for the trailing twelve months (TTM) ended in Jul. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.53 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PURE Bioscience  (OTCPK:PURE) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

PURE Bioscience's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.06758/-0.030
=At Loss

PURE Bioscience's share price for today is $0.06758.
PURE Bioscience's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jul. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.030.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


PURE Bioscience EV-to-FCF Related Terms

Thank you for viewing the detailed overview of PURE Bioscience's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


PURE Bioscience Business Description

Traded in Other Exchanges
N/A
Address
771 Jamacha Road, No. 512, El Cajon, CA, USA, 92019
PURE Bioscience Inc is engaged in developing and commercializing proprietary antimicrobial products. The company's technology platform is based on patented stabilized ionic silver, and its initial products contain silver dihydrogen citrate, or SDC. It offers PURE Hard Surface as a food contact surface sanitizer and disinfectant to restaurant chains, food processors and food transportation companies and PURE Control as a direct food contact processing aid. It also manufactures and sells SDC-based products for end use, and products preserved with SDC and SDC as a raw material ingredient for manufacturing use.
Executives
Robert F Bartlett director 9669 HERMOSA AVENUE, RANCHO CUCAMONGA CA 91730
Bernard Blotner director 9669 HERMOSA AVENUE, RANCHO CUCAMONGA CA 91730
Tom Y Lee director 1807 SAN GABRIEL BLVD., SAN GABRIEL CA 91776
David Rendall director 9669 HERMOSA AVENUE, RANCHO CUCAMONGA CA 91730
Kristin Taylor director 13500 EVENING CREEK DRIVE N, SUITE 550, SAN DIEGO CA 92128
Dale Okuno director 35 N. ARROYO PARKWAY, SUITE 1, PASADENA CA 91103
Ivan Chen director 1725 GILLESPIE WAY, EL CAJON CA 92020
Thomas Richard Myers officer: Chief Operating Officer 1725 GILLESPIE WAY, EL CAJON CA 92130
Henry R. Lambert director, officer: Chief Executive Officer 1725 GILLESPIE WAY, EL CAJON CA 92020
Elisabeth Hagen director 1725 GILLESPIE WAY, EL CAJON CA 92020
Janet Risi Field director 9200 SOUTH DADELAND BOULEVARD, SUITE 800, MIAMI FL 33156
Franchise Brands, Llc 10 percent owner 325 BIC DRIVE, MILFORD CT 06461
Mark Stuart Elliott officer: Vice President, Finance 1725 GILLESPIE WAY, EL CAJON CA 92020
William Otis director 1725 GILLESPIE WAY, EL CAJON CA 92020
David M Theno director 1725 GILLESPIE WAY, EL CAJON CA 92020